SCHEMBL6134902

SCHEMBL6134902

COCCCCCCCOC1CCN(c2ccc(C(=O)OC)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
MAPT P10636 6/20 0.43
PDE6D O43924 1/20 0.42
TSHR P16473 2/20 0.42
ACACB O00763 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GRM2 Q14416 1/20 0.42
LSS P48449 2/20 0.42
HTT P42858 1/20 0.41
USP2 O75604 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
POLB P06746 2/20 0.40
RECQL P46063 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132700 0.95 ALDH1A1 (0.46) ALDH1A1MAPTPDE6DTSHRACACB
SCHEMBL6132706 0.95 ALDH1A1 (0.46) ALDH1A1MAPTPDE6DTSHRACACB
SCHEMBL6132393 0.90 HTT (0.44) ALDH1A1MAPTTSHRSMN1; SMN2HTT
SCHEMBL6132246 0.90 HTT (0.44) ALDH1A1MAPTTSHRSMN1; SMN2HTT
SCHEMBL6134735 0.89 SMYD3 (0.43) ALDH1A1MAPTTSHRACACBLSS
SCHEMBL6132500 0.89 SMYD3 (0.43) ALDH1A1MAPTTSHRACACBLSS
SCHEMBL6132370 0.89 SMYD3 (0.43) ALDH1A1MAPTTSHRACACBLSS
SCHEMBL6132272 0.89 ALDH1A1 (0.41) ALDH1A1MAPTPDE6DTSHRACACB
SCHEMBL6132291 0.89 ALDH1A1 (0.41) ALDH1A1MAPTPDE6DTSHRACACB
SCHEMBL6934067 0.89 ALDH1A1 (0.41) ALDH1A1MAPTPDE6DTSHRACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed
EP-1366066-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-12-03 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 ALDH1A1 3841/4885MAPT 1629/4885PDE6D 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.